首页> 外文期刊>American journal of therapeutics >Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes
【24h】

Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes

机译:糖尿病患者冠状动脉血管造影或经皮冠状动脉介入后对比肾病患者的药物效应及临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the study was to investigate the risk factors of preprocedural laboratory investigations and drug effects to the incidence of contrast-induced nephropathy (CIN) in patients with diabetes who underwent coronary angiography or percutaneous coronary intervention and to assess the short-term safety. We retrospectively studied a total of 568 patients with diabetes who underwent coronary angiography or percutaneous coronary intervention from January, 2013 to January, 2014 in our hospital and compared the baseline clinical characteristics, especially the laboratory investigations and preprocedural drugs of those 2 groups (with CIN group and without CIN group), and half year follow-up. Overall, 53 (9.33%) patients were developed into CIN according to the definition of an increase of 25% from the baseline of serum creatinine concentration, supposing that on the basis of an increase of 44.2 mu mol/L, the incidence would be 0.88% (5/568). No significant differences were found between the 2 groups with respect to age, diabetes mellitus duration, operation type, contrast type and volume, left ventricular ejection fraction, and combined diseases including hypertension, myocardial infarction, Arrhythmia, etc. However, patients with CIN tended to be lighter in body weight (P = 0.027) and were more often female [odds ratio (OR) = 2.8, P<0.01], and also had a higher prevalence with acute coronary syndrome (OR = 5.1, P<0.01). On the contrary to most studies, the preprocedural serum creatinine in with CIN group in our study was lower than without CIN group (P<0.001). As for the preprocedural drugs, statins seemed could decrease the incidence of CIN (OR = 0.34, P<0.05), and the use of diuretics might increase the occurrence of CIN (OR = 2.62, P<0.05). As regard to the follow-up results, the hospitalization days and expense of with CIN group were significantly longer and higher than the without CIN group, but no significance was found between rehospitalization rate in half year. Preprocedural preventions are essential because there is no effective treatment for CIN our findings could be considered in clinical practice. There are many risk factors for CIN; it is necessary to distinguish the high-risk patients so as to carry out corresponding protection actions.
机译:该研究的目的是探讨预培养实验室调查和药物影响对糖尿病患者的糖尿病患者的发病率的危险因素,患有冠状动脉造影或经皮冠状动脉介入的糖尿病或经皮冠状动脉介入和评估短期安全性。我们回顾性研究了568例糖尿病患者,患有冠状动脉造影或经皮冠状动脉干预,从2013年1月到2014年1月在我们的医院中,并比较了基线临床特征,尤其是那些2组的实验室调查和预活化药物(有CIN小组和没有CIN组)和半年随访。总体而言,53例(9.33%)患者根据血清肌酐浓度的基线增加25%的定义,假设在44.2μmmol/ l的基础上,发病率为0.88 %(5/568)。在2组相对于年龄,糖尿病持续时间,手术类型,对比类型和体积,左心室喷射部分和包括高血压,心肌梗塞,心律失常等组合疾病的情况下没有发现显着差异。然而,CIN的患者倾向于在体重较轻(P = 0.027)并且更常见的是雌性[odds比(或)= 2.8,p <0.01],并且还具有急性冠状动脉综合征(或= 5.1,P <0.01)的普遍性。与大多数研究相反,我们研究中与CIN组的预血清血清肌酐低于NATHS,P <0.001)。至于预兴奋药物,他汀类药物似乎可以降低CIN的发生率(或= 0.34,P <0.05),利尿剂的使用可能会增加CIN的发生(或= 2.62,P <0.05)。关于随访结果,CIN组的住院日期和费用显着较长,高于无CIN组,但在半年内没有发现再生生长率之间的重要性。预先预防预防是必不可少的,因为没有有效治疗Cin,我们的研究结果可以在临床实践中考虑。 CIN有许多风险因素;有必要区分高风险患者以执行相应的保护行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号